nodes	percent_of_prediction	percent_of_DWPC	metapath
MACITENTAN—ALB—acquired immunodeficiency syndrome	0.337	1	CbGaD
MACITENTAN—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.041	0.0783	CbGbCtD
MACITENTAN—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0407	0.0778	CbGbCtD
MACITENTAN—ALB—Zidovudine—acquired immunodeficiency syndrome	0.039	0.0746	CbGbCtD
MACITENTAN—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0385	0.0736	CbGbCtD
MACITENTAN—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0348	0.0665	CbGbCtD
MACITENTAN—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0348	0.0665	CbGbCtD
MACITENTAN—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0301	0.0574	CbGbCtD
MACITENTAN—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0292	0.0558	CbGbCtD
MACITENTAN—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0264	0.0504	CbGbCtD
MACITENTAN—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0264	0.0504	CbGbCtD
MACITENTAN—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0253	0.0483	CbGbCtD
MACITENTAN—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0198	0.0378	CbGbCtD
MACITENTAN—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0186	0.0356	CbGbCtD
MACITENTAN—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0186	0.0356	CbGbCtD
MACITENTAN—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0168	0.0322	CbGbCtD
MACITENTAN—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0168	0.0322	CbGbCtD
MACITENTAN—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0145	0.0278	CbGbCtD
MACITENTAN—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0141	0.027	CbGbCtD
MACITENTAN—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0128	0.0244	CbGbCtD
MACITENTAN—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0128	0.0244	CbGbCtD
MACITENTAN—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0122	0.0234	CbGbCtD
MACITENTAN—Hepatotoxicity—Didanosine—acquired immunodeficiency syndrome	0.0031	0.0395	CcSEcCtD
MACITENTAN—Hepatotoxicity—Nevirapine—acquired immunodeficiency syndrome	0.00279	0.0355	CcSEcCtD
MACITENTAN—Hepatotoxicity—Stavudine—acquired immunodeficiency syndrome	0.00269	0.0343	CcSEcCtD
MACITENTAN—EDNRB—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.00212	0.0453	CbGpPWpGaD
MACITENTAN—Hepatotoxicity—Efavirenz—acquired immunodeficiency syndrome	0.00205	0.0262	CcSEcCtD
MACITENTAN—EDNRB—retina—acquired immunodeficiency syndrome	0.00183	0.126	CbGeAlD
MACITENTAN—Hepatotoxicity—Ritonavir—acquired immunodeficiency syndrome	0.00182	0.0232	CcSEcCtD
MACITENTAN—Fluid retention—Zidovudine—acquired immunodeficiency syndrome	0.00171	0.0218	CcSEcCtD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.00165	0.0352	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.00152	0.0324	CbGpPWpGaD
MACITENTAN—Influenza—Stavudine—acquired immunodeficiency syndrome	0.0013	0.0166	CcSEcCtD
MACITENTAN—EDNRA—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.00129	0.0275	CbGpPWpGaD
MACITENTAN—Bronchitis—Stavudine—acquired immunodeficiency syndrome	0.00125	0.016	CcSEcCtD
MACITENTAN—Bronchitis—Abacavir—acquired immunodeficiency syndrome	0.00123	0.0157	CcSEcCtD
MACITENTAN—EDNRB—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.00118	0.0253	CbGpPWpGaD
MACITENTAN—EDNRB—spinal cord—acquired immunodeficiency syndrome	0.00118	0.0812	CbGeAlD
MACITENTAN—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00118	0.0812	CbGeAlD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.00118	0.0252	CbGpPWpGaD
MACITENTAN—Nasopharyngitis—Zidovudine—acquired immunodeficiency syndrome	0.00117	0.0149	CcSEcCtD
MACITENTAN—EDNRB—vagina—acquired immunodeficiency syndrome	0.00113	0.0782	CbGeAlD
MACITENTAN—Influenza—Zidovudine—acquired immunodeficiency syndrome	0.00113	0.0144	CcSEcCtD
MACITENTAN—Urinary tract infection—Stavudine—acquired immunodeficiency syndrome	0.00113	0.0144	CcSEcCtD
MACITENTAN—EDNRB—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.00111	0.0238	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.0011	0.0236	CbGpPWpGaD
MACITENTAN—EDNRB—lung—acquired immunodeficiency syndrome	0.00107	0.0739	CbGeAlD
MACITENTAN—Pharyngitis—Nelfinavir—acquired immunodeficiency syndrome	0.00104	0.0132	CcSEcCtD
MACITENTAN—Pharyngitis—Stavudine—acquired immunodeficiency syndrome	0.00104	0.0132	CcSEcCtD
MACITENTAN—Nasopharyngitis—Efavirenz—acquired immunodeficiency syndrome	0.00103	0.0131	CcSEcCtD
MACITENTAN—Pharyngitis—Abacavir—acquired immunodeficiency syndrome	0.00102	0.013	CcSEcCtD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.000997	0.0213	CbGpPWpGaD
MACITENTAN—Anaemia—Didanosine—acquired immunodeficiency syndrome	0.000967	0.0123	CcSEcCtD
MACITENTAN—Influenza—Delavirdine—acquired immunodeficiency syndrome	0.000952	0.0121	CcSEcCtD
MACITENTAN—Angiopathy—Nelfinavir—acquired immunodeficiency syndrome	0.000949	0.0121	CcSEcCtD
MACITENTAN—EDNRA—vagina—acquired immunodeficiency syndrome	0.000938	0.0646	CbGeAlD
MACITENTAN—Nervous system disorder—Amprenavir—acquired immunodeficiency syndrome	0.000918	0.0117	CcSEcCtD
MACITENTAN—Bronchitis—Delavirdine—acquired immunodeficiency syndrome	0.000916	0.0117	CcSEcCtD
MACITENTAN—Urinary tract infection—Indinavir—acquired immunodeficiency syndrome	0.000913	0.0116	CcSEcCtD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000902	0.0193	CbGpPWpGaD
MACITENTAN—Pharyngitis—Zidovudine—acquired immunodeficiency syndrome	0.0009	0.0115	CcSEcCtD
MACITENTAN—ALB—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.00089	0.019	CbGpPWpGaD
MACITENTAN—Infestation—Efavirenz—acquired immunodeficiency syndrome	0.000888	0.0113	CcSEcCtD
MACITENTAN—Infestation NOS—Efavirenz—acquired immunodeficiency syndrome	0.000888	0.0113	CcSEcCtD
MACITENTAN—EDNRA—lung—acquired immunodeficiency syndrome	0.000887	0.0611	CbGeAlD
MACITENTAN—Influenza—Ritonavir—acquired immunodeficiency syndrome	0.000881	0.0112	CcSEcCtD
MACITENTAN—Anaemia—Nevirapine—acquired immunodeficiency syndrome	0.000869	0.0111	CcSEcCtD
MACITENTAN—Infection—Didanosine—acquired immunodeficiency syndrome	0.000848	0.0108	CcSEcCtD
MACITENTAN—EDNRA—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.000848	0.0181	CbGpPWpGaD
MACITENTAN—Influenza—Saquinavir—acquired immunodeficiency syndrome	0.000848	0.0108	CcSEcCtD
MACITENTAN—Bronchitis—Ritonavir—acquired immunodeficiency syndrome	0.000847	0.0108	CcSEcCtD
MACITENTAN—Anaemia—Nelfinavir—acquired immunodeficiency syndrome	0.000842	0.0107	CcSEcCtD
MACITENTAN—EDNRB—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000841	0.018	CbGpPWpGaD
MACITENTAN—Anaemia—Stavudine—acquired immunodeficiency syndrome	0.000839	0.0107	CcSEcCtD
MACITENTAN—Pharyngitis—Indinavir—acquired immunodeficiency syndrome	0.000837	0.0107	CcSEcCtD
MACITENTAN—Nasopharyngitis—Lamivudine—acquired immunodeficiency syndrome	0.000837	0.0107	CcSEcCtD
MACITENTAN—Anaemia—Abacavir—acquired immunodeficiency syndrome	0.000827	0.0105	CcSEcCtD
MACITENTAN—Urinary tract infection—Delavirdine—acquired immunodeficiency syndrome	0.000825	0.0105	CcSEcCtD
MACITENTAN—Bronchitis—Saquinavir—acquired immunodeficiency syndrome	0.000815	0.0104	CcSEcCtD
MACITENTAN—Influenza—Lamivudine—acquired immunodeficiency syndrome	0.000809	0.0103	CcSEcCtD
MACITENTAN—EDNRA—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.000797	0.017	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00079	0.0169	CbGpPWpGaD
MACITENTAN—Bronchitis—Lamivudine—acquired immunodeficiency syndrome	0.000778	0.00991	CcSEcCtD
MACITENTAN—Oedema—Nevirapine—acquired immunodeficiency syndrome	0.000768	0.00978	CcSEcCtD
MACITENTAN—EDNRB—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.000763	0.0163	CbGpPWpGaD
MACITENTAN—Urinary tract infection—Ritonavir—acquired immunodeficiency syndrome	0.000763	0.00972	CcSEcCtD
MACITENTAN—EDNRB—brain—acquired immunodeficiency syndrome	0.000759	0.0523	CbGeAlD
MACITENTAN—Pharyngitis—Delavirdine—acquired immunodeficiency syndrome	0.000757	0.00964	CcSEcCtD
MACITENTAN—Infestation NOS—Saquinavir—acquired immunodeficiency syndrome	0.000756	0.00963	CcSEcCtD
MACITENTAN—Infestation—Saquinavir—acquired immunodeficiency syndrome	0.000756	0.00963	CcSEcCtD
MACITENTAN—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.000753	0.00959	CcSEcCtD
MACITENTAN—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.000743	0.00947	CcSEcCtD
MACITENTAN—Urinary tract infection—Saquinavir—acquired immunodeficiency syndrome	0.000735	0.00936	CcSEcCtD
MACITENTAN—EDNRB—lymph node—acquired immunodeficiency syndrome	0.000734	0.0506	CbGeAlD
MACITENTAN—Oedema—Abacavir—acquired immunodeficiency syndrome	0.00073	0.0093	CcSEcCtD
MACITENTAN—Anaemia—Zidovudine—acquired immunodeficiency syndrome	0.00073	0.00929	CcSEcCtD
MACITENTAN—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.000727	0.00926	CcSEcCtD
MACITENTAN—Infection—Abacavir—acquired immunodeficiency syndrome	0.000725	0.00924	CcSEcCtD
MACITENTAN—Angiopathy—Efavirenz—acquired immunodeficiency syndrome	0.000723	0.00921	CcSEcCtD
MACITENTAN—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.000716	0.00912	CcSEcCtD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.000714	0.0153	CbGpPWpGaD
MACITENTAN—Pharyngitis—Ritonavir—acquired immunodeficiency syndrome	0.0007	0.00891	CcSEcCtD
MACITENTAN—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000697	0.048	CbGeAlD
MACITENTAN—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.000682	0.00869	CcSEcCtD
MACITENTAN—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.000679	0.00864	CcSEcCtD
MACITENTAN—Pharyngitis—Saquinavir—acquired immunodeficiency syndrome	0.000673	0.00858	CcSEcCtD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000669	0.0143	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000646	0.0138	CbGpPWpGaD
MACITENTAN—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.000644	0.00821	CcSEcCtD
MACITENTAN—Pharyngitis—Lamivudine—acquired immunodeficiency syndrome	0.000642	0.00818	CcSEcCtD
MACITENTAN—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000641	0.00817	CcSEcCtD
MACITENTAN—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.00064	0.00815	CcSEcCtD
MACITENTAN—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000632	0.00805	CcSEcCtD
MACITENTAN—EDNRA—brain—acquired immunodeficiency syndrome	0.000628	0.0433	CbGeAlD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000616	0.0132	CbGpPWpGaD
MACITENTAN—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.000616	0.00784	CcSEcCtD
MACITENTAN—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000613	0.00781	CcSEcCtD
MACITENTAN—EDNRA—lymph node—acquired immunodeficiency syndrome	0.000606	0.0418	CbGeAlD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000605	0.0129	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000602	0.0129	CbGpPWpGaD
MACITENTAN—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000599	0.00763	CcSEcCtD
MACITENTAN—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000588	0.00748	CcSEcCtD
MACITENTAN—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000587	0.00747	CcSEcCtD
MACITENTAN—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000567	0.00723	CcSEcCtD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000557	0.0119	CbGpPWpGaD
MACITENTAN—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000555	0.00707	CcSEcCtD
MACITENTAN—EDNRA—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.000546	0.0117	CbGpPWpGaD
MACITENTAN—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000546	0.00695	CcSEcCtD
MACITENTAN—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000542	0.0069	CcSEcCtD
MACITENTAN—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000538	0.00685	CcSEcCtD
MACITENTAN—Headache—Didanosine—acquired immunodeficiency syndrome	0.000535	0.00681	CcSEcCtD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000524	0.0112	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000524	0.0112	CbGpPWpGaD
MACITENTAN—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000521	0.00663	CcSEcCtD
MACITENTAN—EDNRB—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000509	0.0109	CbGpPWpGaD
MACITENTAN—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000506	0.00645	CcSEcCtD
MACITENTAN—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000501	0.00638	CcSEcCtD
MACITENTAN—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000491	0.00626	CcSEcCtD
MACITENTAN—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000482	0.00614	CcSEcCtD
MACITENTAN—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000481	0.00613	CcSEcCtD
MACITENTAN—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000479	0.0061	CcSEcCtD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000479	0.0102	CbGpPWpGaD
MACITENTAN—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000473	0.00602	CcSEcCtD
MACITENTAN—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000468	0.00596	CcSEcCtD
MACITENTAN—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000466	0.00593	CcSEcCtD
MACITENTAN—Headache—Stavudine—acquired immunodeficiency syndrome	0.000464	0.00591	CcSEcCtD
MACITENTAN—EDNRA—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.000463	0.0099	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000461	0.00985	CbGpPWpGaD
MACITENTAN—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00046	0.00586	CcSEcCtD
MACITENTAN—Headache—Abacavir—acquired immunodeficiency syndrome	0.000457	0.00583	CcSEcCtD
MACITENTAN—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000457	0.00582	CcSEcCtD
MACITENTAN—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000453	0.0312	CbGeAlD
MACITENTAN—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000451	0.00574	CcSEcCtD
MACITENTAN—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00045	0.00574	CcSEcCtD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000441	0.00943	CbGpPWpGaD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000436	0.00933	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000433	0.00926	CbGpPWpGaD
MACITENTAN—CYP2C19—blood—acquired immunodeficiency syndrome	0.000432	0.0297	CbGeAlD
MACITENTAN—EDNRB—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000432	0.00922	CbGpPWpGaD
MACITENTAN—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00043	0.00547	CcSEcCtD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000413	0.00884	CbGpPWpGaD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00041	0.00877	CbGpPWpGaD
MACITENTAN—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000404	0.00514	CcSEcCtD
MACITENTAN—CYP2C19—vagina—acquired immunodeficiency syndrome	0.0004	0.0276	CbGeAlD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000399	0.00853	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000399	0.00852	CbGpPWpGaD
MACITENTAN—Headache—Indinavir—acquired immunodeficiency syndrome	0.000375	0.00478	CcSEcCtD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000375	0.00802	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000375	0.00802	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000374	0.00799	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000365	0.00779	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000359	0.00768	CbGpPWpGaD
MACITENTAN—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000355	0.00452	CcSEcCtD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000351	0.00751	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000351	0.00751	CbGpPWpGaD
MACITENTAN—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000339	0.00432	CcSEcCtD
MACITENTAN—ALB—brain—acquired immunodeficiency syndrome	0.000333	0.0229	CbGeAlD
MACITENTAN—EDNRA—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00033	0.00705	CbGpPWpGaD
MACITENTAN—ALB—lymph node—acquired immunodeficiency syndrome	0.000321	0.0222	CbGeAlD
MACITENTAN—EDNRB—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000315	0.00673	CbGpPWpGaD
MACITENTAN—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000314	0.004	CcSEcCtD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000312	0.00667	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000309	0.0066	CbGpPWpGaD
MACITENTAN—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000302	0.00385	CcSEcCtD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000296	0.00632	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000294	0.00628	CbGpPWpGaD
MACITENTAN—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000288	0.00367	CcSEcCtD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000285	0.0061	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000285	0.00608	CbGpPWpGaD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000281	0.00601	CbGpPWpGaD
MACITENTAN—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000268	0.0185	CbGeAlD
MACITENTAN—EDNRB—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000268	0.00572	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000268	0.00572	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000268	0.00572	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000267	0.00572	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000261	0.00559	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000257	0.00549	CbGpPWpGaD
MACITENTAN—CYP3A4—blood—acquired immunodeficiency syndrome	0.000255	0.0176	CbGeAlD
MACITENTAN—EDNRB—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000255	0.00545	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000252	0.00538	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000252	0.00538	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000241	0.00515	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000236	0.00505	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000225	0.00482	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.000215	0.00459	CbGpPWpGaD
MACITENTAN—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000207	0.0143	CbGeAlD
MACITENTAN—EDNRA—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000204	0.00435	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000204	0.00435	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000201	0.0043	CbGpPWpGaD
MACITENTAN—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000199	0.0137	CbGeAlD
MACITENTAN—EDNRA—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000192	0.00409	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000192	0.00409	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000191	0.00409	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000187	0.004	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000183	0.00392	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000182	0.0039	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000172	0.00369	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.000169	0.00362	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000169	0.00362	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000162	0.00345	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000161	0.00344	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000154	0.0033	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000154	0.0033	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000151	0.00323	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000151	0.00323	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000146	0.00312	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000146	0.00311	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00014	0.00299	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000137	0.00294	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000137	0.00294	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000131	0.00281	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.000126	0.00269	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000116	0.00247	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000115	0.00246	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000115	0.00246	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000113	0.00242	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000111	0.00236	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000111	0.00236	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.00011	0.00236	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000108	0.00231	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000108	0.00231	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000105	0.00223	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000104	0.00223	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000104	0.00222	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000103	0.0022	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.000102	0.00219	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.0001	0.00214	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	9.83e-05	0.0021	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	9.83e-05	0.0021	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	9.76e-05	0.00209	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.54e-05	0.00204	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.41e-05	0.00201	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IL2—acquired immunodeficiency syndrome	9.09e-05	0.00194	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	8.76e-05	0.00187	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.63e-05	0.00184	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.23e-05	0.00176	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	8.14e-05	0.00174	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	8.13e-05	0.00174	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.11e-05	0.00173	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.11e-05	0.00173	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.11e-05	0.00173	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	7.91e-05	0.00169	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	7.48e-05	0.0016	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.42e-05	0.00159	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.37e-05	0.00157	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	6.83e-05	0.00146	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	6.74e-05	0.00144	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—TNF—acquired immunodeficiency syndrome	6.62e-05	0.00142	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	6.57e-05	0.0014	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	6.54e-05	0.0014	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.18e-05	0.00132	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.17e-05	0.00132	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.08e-05	0.0013	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.99e-05	0.00128	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.81e-05	0.00124	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.81e-05	0.00124	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.56e-05	0.00119	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.44e-05	0.00116	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IL6—acquired immunodeficiency syndrome	5.35e-05	0.00114	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	5.26e-05	0.00112	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—TAT—acquired immunodeficiency syndrome	5.11e-05	0.00109	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—TAT—acquired immunodeficiency syndrome	4.59e-05	0.000981	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.42e-05	0.000944	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.35e-05	0.00093	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—AGPS—acquired immunodeficiency syndrome	4.35e-05	0.000929	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IFNA1—acquired immunodeficiency syndrome	4.31e-05	0.000922	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.29e-05	0.000916	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	4.25e-05	0.000908	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.98e-05	0.000851	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—AGPS—acquired immunodeficiency syndrome	3.9e-05	0.000834	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.89e-05	0.000832	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	3.46e-05	0.000739	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—CSF2—acquired immunodeficiency syndrome	3.37e-05	0.000721	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.21e-05	0.000687	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.2e-05	0.000683	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	2.76e-05	0.00059	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	2.35e-05	0.000502	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.3e-05	0.000492	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.29e-05	0.000489	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.89e-05	0.000404	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.8e-05	0.000384	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IL2—acquired immunodeficiency syndrome	1.78e-05	0.000381	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.35e-05	0.000289	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	8e-06	0.000171	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	4.81e-06	0.000103	CbGpPWpGaD
